Kelsey Quick, PA
Gynecology · Pasadena, MDNPI 1104428275
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 44 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 34.0% of the total. That places this record below the midpoint for gynecology clinicians in MD, where the typical reported total is $794.
Across 44 payments — averaging $18.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$283
- Mayne Pharma Commercial LLC$90
- Therapeuticsmd, Inc.$87
- Exeltis, USA Inc.$75
- Coopersurgical, Inc.$62
- Aspira Women's Health Inc$38
- plus $198 from 9 others
What the payments were for
- Food & beverage$834100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $283 |
| Mayne Pharma Commercial LLC | 4 | $90 |
| Therapeuticsmd, Inc. | 4 | $87 |
| Exeltis, USA Inc. | 4 | $75 |
| Coopersurgical, Inc. | 3 | $62 |
| Aspira Women's Health Inc | 2 | $38 |
| Myovant Sciences Inc. | 2 | $36 |
| Hologic Sales And Service, LLC | 1 | $33 |
| Pfizer | 1 | $32 |
| Bayer | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Avion Pharmaceuticals | 1 | $18 |
| Axonics, Inc. | 1 | $18 |
| Evofem Biosciences, Inc. | 1 | $13 |
| Organon | 1 | $5 |
How this compares
$834 in reported general payments places this provider in the 50th percentile of 79 gynecology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 31 | $583 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 28 | $197 |
| Azithromycin | 25 | $163 |
| Mupirocin | 12 | $109 |
| Fluticasone Propionate | 12 | $107 |
| Prednisone | 53 | $104 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $86 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Pasadena
- Vadim MorozovBaltimore$394K
- Andrew LondonLutherville$335K
- Richard MarvelAnnapolis$40K
- Ann PetersBaltimore$25K
- David ZisowForest Hill$24K
- Hector Gonzalez GarciaAnnapolis$23K
- Farinaz SeifiBaltimore$17K
- Christine HelouBaltimore$11K
- Ronald OrleansBethesda$8K
- Parabhdeep GillAnnapolis$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.